Clinical Trials Browser

OTHER × Peritoneal Neoplasms × Clear all

NCT04220827 2026-04-15

Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer

Phase 1 Active not recruiting

Peritoneal Neoplasms

NCT01226394 2026-04-06

ProphyloCHIP

Phase 3 Completed

Krukenberg Tumor, Peritoneal Neoplasms

NCT07493876 2026-04-03

EPICH

Phase NA Recruiting

Peritoneal Neoplasms

NCT04779554 2026-04-01

Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

Phase 2 Recruiting

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT07241091 2026-03-30

SurgiPerito Trial: High-Purity Type-I Collagen for Peritoneal Reconstruction After Cytoreductive Surgery

Phase NA Completed

60 enrolled 16 charts

Intestinal Obstruction, Ovarian Neoplasms, Peritoneal Neoplasms

NCT02758951 2026-03-24

CAIRO6

Phase 2/3 Active not recruiting

GastrointestinalGynecologic

Hyperthermia, Colonic Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT07487168 2026-03-23

Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors

Phase 1 Not yet recruiting

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Diseases, Peritoneal Neoplasms, Colorectal Neoplasms

NCT07478107 2026-03-20

OSNA

Peritoneal Neoplasms

NCT06144853 2026-03-16

The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study.

Peritoneal Neoplasms

NCT07451483 2026-03-05

Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

GastrointestinalGynecologic

Hernia, Ventral, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Colorectal Neoplasms

NCT06511037 2026-02-27

PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis

Phase EARLY_PHASE1 Recruiting

GastrointestinalGynecologic

Gastrointestinal Neoplasms, Peritoneal Neoplasms

NCT07282834 2026-02-27

Charlie-2

Phase 2 Recruiting

Neoplasm Metastasis, Neoplasms, Peritoneal Neoplasms

NCT05159050 2026-02-25

Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal Carcinomatosis

Phase 1 Terminated

Peritoneal Neoplasms

NCT03252938 2026-02-19

INSIGHT

Phase 1 Active not recruiting

GenitourinaryGynecologic

Carcinoma, Transitional Cell, Peritoneal Neoplasms

NCT06929013 2026-02-13

NUCLEAR

Phase NA Recruiting

Peritoneal Neoplasms

NCT06623396 2026-02-11

A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Phase 1 Recruiting

BreastGastrointestinalGynecologic

Adenocarcinoma Of Esophagus, Breast Neoplasms, Diabetes Mellitus, Peritoneal Neoplasms

NCT03875144 2026-02-09

MESOTIP

Phase 2 Suspended

Peritoneal Neoplasms

NCT04762953 2026-02-03

STOPGAP

Phase 2 Active not recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT07030283 2026-02-02

Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis

Phase 1 Recruiting

Neoplasm Metastasis, Peritoneal Neoplasms

NCT02012699 2026-01-22

iCaRe2

999,999 enrolled

BreastCNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETOther hematologic neoplasmOther solid neoplasmPlasma cellSarcomaThoracic

Anus Neoplasms, Bile Duct Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Duodenal Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Hypopharyngeal Neoplasms, Kidney Neoplasms, Laryngeal Neoplasms, Leukemia, Lip Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Mesothelioma, Mouth Neoplasms, Multiple Myeloma, Nasopharyngeal Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Paranasal Sinus Neoplasms, Paraproteinemias, Penile Neoplasms, Peritoneal Neoplasms, Adenomatous Polyposis Coli, Prostatic Neoplasms, Rectal Neoplasms, Salivary Gland Neoplasms, Sarcoma, Skin Neoplasms, Stomach Neoplasms, Testicular Neoplasms, Thymus Neoplasms, Thyroid Neoplasms, Ureteral Neoplasms, Urethral Neoplasms, Vaginal Neoplasms, Central Nervous System Neoplasms, Thyroid Nodule, Endometrial Neoplasms, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors

NCT04024917 2026-01-16

COCOON

Phase NA Recruiting

Peritoneal Neoplasms, Pseudomyxoma Peritonei

NCT01226550 2025-12-19

Treatment of Primary Peritoneal Carcinosis of Digestive Origin Using Cytoreductive Surgery and Hyperthermic Intraoperative Peritoneal Chemotherapy With Mitomycin C and Irinotecan

Phase 1/2 Completed

Peritoneal Neoplasms

NCT02823860 2025-12-19

BIG-RENAPE

Phase NA Completed

Peritoneal Neoplasms

NCT04329494 2025-12-10

PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer

Phase 1 Recruiting

GastrointestinalGynecologic

Appendiceal Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Uterine Neoplasms, Colorectal Neoplasms

NCT07273396 2025-12-09

Tolerance, Safety, Efficacy, and Pharmacokinetics of Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Using Paclitaxel for Platinum-resistant Recurrent Ovarian Cancer

Phase 1/2 Not yet recruiting

Ovarian Neoplasms, Peritoneal Neoplasms

NCT06351475 2025-12-05

ALBUCHIP

Phase NA Recruiting

Peritoneal Neoplasms, Postoperative Complications

NCT04107077 2025-10-07

Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer

Phase 2 Recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT03127774 2025-10-03

Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma

Phase 2 Recruiting

EndocrineGynecologic

Peritoneal Neoplasms, Adrenocortical Carcinoma

NCT05644249 2025-09-24

PIPAC and FOLFOX for Gastric Cancer Peritoneal Cancer

Phase NA Completed

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT00766142 2025-08-29

COCHISE

Phase 2 Terminated

18 enrolled 9 charts

GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06839092 2025-07-30

PROPAC

Phase 3 Not yet recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Colorectal Neoplasms

NCT05844865 2025-07-29

Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis

Phase NA Recruiting

Peritoneal Neoplasms

NCT04766502 2025-07-24

PIPADN

Phase NA Completed

Peritoneal Neoplasms

NCT03348150 2025-07-17

PERISCOPEII

Phase 3 Active not recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT05277766 2025-07-01

PIPAC-NAL-IRI

Phase 1 Recruiting

GastrointestinalGynecologic

Appendiceal Neoplasms, Bile Duct Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT02228889 2025-06-06

RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction

Phase NA Completed

46 enrolled 7 charts

GynecologicSarcoma

Hernia, Hernia, Ventral, Intestinal Fistula, Peritoneal Neoplasms, Fibromatosis, Abdominal, Desmoid Tumors

NCT05652348 2025-05-29

Hi-STEP1

GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms, Stomach Neoplasms

NCT02571725 2025-05-23

PARP-inhibition and CTLA-4 Blockade in BRCA-deficient Ovarian Cancer

Phase 1/2 Active not recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

NCT03508570 2025-05-22

Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis

Phase 1 Completed

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, Endometrial Neoplasms

NCT06784765 2025-05-09

Preventive Use of PIPAC in Locally Advanced Gastric Cancer.

Phase NA Recruiting

GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT06061874 2025-03-31

FAPeCa

Phase NA Recruiting

GastrointestinalGynecologic

Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms, Colorectal Neoplasms

NCT05340569 2025-03-20

DWI-PDAC

Phase NA Completed

GastrointestinalGynecologic

Carcinoma, Pancreatic Neoplasms, Peritoneal Neoplasms

NCT05623787 2025-03-20

DWI-HighRisk

Phase NA Active not recruiting

GastrointestinalGynecologic

Appendiceal Neoplasms, Carcinoma, Peritoneal Neoplasms, Colorectal Neoplasms

NCT03976999 2025-02-12

BCBOvaire

Phase NA Recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasms, Peritoneal Neoplasms

NCT05633836 2025-01-24

MicroFluO

Phase NA Completed

Ovarian Neoplasms, Peritoneal Neoplasms

NCT03663712 2024-11-20

TEMPO

Phase 1 Completed

28 enrolled 10 charts

Peritoneal Neoplasms

NCT02040142 2024-10-24

HIPEC for Peritoneal Carcinomatosis

Phase 2 Completed

51 enrolled 12 charts

GastrointestinalGynecologic

Appendiceal Neoplasms, Peritoneal Neoplasms, Pseudomyxoma Peritonei, Stomach Neoplasms, Colorectal Neoplasms

NCT05250648 2024-10-09

GECOP-MMC

Phase 4 Recruiting

GastrointestinalGynecologic

Colonic Neoplasms, Peritoneal Neoplasms

NCT02891447 2024-09-19

Heated Mitomycin and Cisplatin During Surgery in Treating Patients With Stomach or Gastroesophageal Cancer

Phase 2 Completed

24 enrolled 10 charts

Peritoneal Neoplasms

NCT03777943 2024-09-19

MMT

Peritoneal Neoplasms